(Q31962811)

English

Effect of adding selegiline to levodopa in early, mild Parkinson's disease. Formal systematic review of data on patients in all relevant trials is required

scientific article

Effect of adding selegiline to levodopa in early, mild Parkinson's disease

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

5 July 2017

0 references

Effect of adding selegiline to levodopa in early, mild Parkinson's disease. Formal systematic review of data on patients in all relevant trials is required (English)

1 reference

Europe PubMed Central

5 July 2017

Parkinson's disease

0 references

1 reference

based on heuristic

inferred from title

author name string

C Counsell

1

1 reference

Europe PubMed Central

5 July 2017

language of work or name

0 references

publication date

1 December 1998

1 reference

Europe PubMed Central

5 July 2017

1 reference

Europe PubMed Central

5 July 2017

317

1 reference

Europe PubMed Central

5 July 2017

7172

1 reference

Europe PubMed Central

5 July 2017

1586

1 reference

Europe PubMed Central

5 July 2017

Effect of selegiline on mortality in patients with Parkinson's disease: a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1114394

21 June 2018

Investigation by Parkinson's Disease Research Group of United Kingdom into excess mortality seen with combined levodopa and selegiline treatment in patients with early, mild Parkinson's disease: further results of randomised trial and confidential i

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1114394

21 June 2018

The effects of early selegiline therapy on long-term levodopa treatment and parkinsonian disability: an interim analysis of a Norwegian--Danish 5-year study. Norwegian-Danish Study Group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1114394

31 October 2018

Effect of adding selegeline to levodopa in early, mild Parkinson's disease. Other studies have not shown increased mortality

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1114394

31 October 2018

Increased life expectancy resulting from addition of L-deprenyl to Madopar treatment in Parkinson's disease: a longterm study

1 reference

https://pubmed.ncbi.nlm.nih.gov/9836669

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selegiline as the primary treatment of Parkinson's disease--a long-term double-blind study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9836669

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mortality in DATATOP: a multicenter trial in early Parkinson's disease. Parkinson Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/9836669

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/BMJ.317.7172.1586

1 reference

Europe PubMed Central

5 July 2017

1 reference

Europe PubMed Central

5 July 2017

1 reference

Europe PubMed Central

5 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31962811&oldid=1602837886"